Human medicines European public assessment report (EPAR): Rixubis, nonacog gamma, Date of authorisation: 19/12/2014, Revision: 12, Status: Authorised
Scientific guidelines with summary-of-product-characteristics recommendations
List of medicinal products under additional monitoring
List of medicinal products under additional monitoring
The role of members representing patients' and healthcare professionals' organisations on EMA scientific committees
Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Date of authorisation: 19/03/2001, Revision: 24, Status: Authorised
Minutes of the PRAC meeting on 30 September - 03 October 2024
Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Date of authorisation: 20/09/2007, Revision: 42, Status: Authorised
List of medicines currently in PRIME scheme
LinkedIn Live session: Improving efficiency of approval process for new medicines in the EU , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 December 2024, 12:30 (CET) to 5 December 2024, 13:30 (CET)